Confab to highlight Israeli biotech cos.

By Marie Szaniszlo

Monday, November 5, 2012 – Updated 1 week ago

More than 250 leaders in the life sciences industry, researchers, health care providers and investors will gather in Waltham beginning today for the third New England-Israel Business Council Life Sciences Summit.

The two-day forum at the Westin Hotel will feature more than 50 speakers who will discuss key issues affecting today’s delivery of health care and present promising Israeli life sciences companies addressing tomorrow’s challenges.

“The hope is to create new interactions between the Massachusetts and Israel life sciences ecosystems and invite a dozen Israeli companies to present their technologies,” said David Barone, chairman of the council’s life sciences committee and principal at Boston MedTech Advisors. “There are very significant collaborations already going on.”

As a result of Gov.Deval Patrick’s 2011 trade mission to Israel, EarlySense, an Israeli company that has developed a system to alert nurses to changes in hospitalized patients’ conditions, later opened its U.S. headquarters in Waltham, Barone said.

This year, Covidien, a $12 billion global health care products company whose U.S. headquarters is in Mansfield, acquired three Israeli companies.

“The hunger for innovation and the recognition that ideas are the new commodity create a tremendous demand for forums like this,” said Dr. Ido Schoenberg, a native Israeli and CEO of Boston-based teleheath company American Well Corp. “Innovation needs to be part of an ecosystem. It cannot stand alone.”

You can leave a response, or trackback from your own site.

Leave a Reply